Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is H and Author is Huang, Ching-Ying  [Clear All Filters]
2023
Cheng Y-C, Hsieh ML, Lin C-J, Chang CMC, Huang C-Y, Puntney R, Moy AWu, Ting C-Y, Chan DZhing Herr, Nicholson MW, et al. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates. Circulation. 2023.
2022
Chien C-Y, Lin J-C, Huang C-Y, Hsu C-Y, Yang K-C, Chattopadhyay S, Nikoloutsos N, Hsieh PChing-Ho, Hu C-MJack. In Situ Hydrogelation of Cellular Monolayers Enables Conformal Biomembrane Functionalization for Xeno-Free Feeder Substrate Engineering. Adv Healthc Mater. 2022:e2201708.
2021
Tsai M-H, Chiu Y-T, Chan DZhing-Herr, Wen C-H, Syu S-H, Lu H-E, Huang C-YF, Lin Y-J, Chang S-L, Lo L-W, et al. Generation of IBMS-iPSC-021, -022, -023 human induced pluripotent stem cells (IBMSi016-A, IBMSi017-A, and IBMSi018-A) derived from patients with the ALDH2 rs671 polymorphism. Stem Cell Res. 2021;54:102416.
Ting C-Y, Huang C-Y, Chen H-C, Chiu Y-W, Hsieh PCH, Lee J-J. Generation of induced pluripotent stem cells from a Bardet-Biedl syndrome patient carrying a homologous BBS2 c.534 + 1G > T mutation. Stem Cell Res. 2021;55:102480.
2020
Liu C-L, Huang C-Y, Chen H-C, Lu H-E, Hsieh PCH, Lee J-J. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Res. 2020;45:101784.
2019
Lin H-I, Cheng Y-C, Ko H-W, Wen C-H, Lu H-E, Huang C-Y, Hsieh PCH, Lin C-H. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation. Stem Cell Res. 2019;37:101447.
Huang C-Y, Liu C-L, Ting C-Y, Chiu Y-T, Cheng Y-C, Nicholson MW, Hsieh PCH. Human iPSC banking: barriers and opportunities. J Biomed Sci. 2019;26(1):87.
Cheng Y-C, Lin H-I, Syu S-H, Lu H-E, Huang C-Y, Lin C-H, Hsieh PCH. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene. Stem Cell Res. 2019;37:101432.